Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01850589 · ClinicalTrials.gov registry record · NA

Comparison of Conservative and Aggressive Smoking Cessation Treatment Strategies in a Vascular Surgery Office Practice

A NA study, sponsored by Northwell Health.

Terminated
Registry status
NA
Development phase
44
Enrollment target

NCT01850589: Clinical Trial NA study, sponsored by Northwell Health.

NCT01850589 is a NA study that was terminated before completion, run by Northwell Health. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01850589, a NA study, was terminated before completion, sponsored by Northwell Health.

TERMINATED
Registry status
NA
Development phase
44 participants
Enrollment target

Study Summary

The aim of this study is to prove that the use of Bupropion with counseling works better than counseling alone for patients to quit smoking. The belief is that overall, there is a small percentage of patients who quit smoking all together.

Primary Outcome

Conservative vs. aggressive smoking strategies in treating smoking cessation.

Interventions

  • OTHER Aggressive Therapy

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2011-03
Est. Completion 2013-01
Phase NA
Northwell Health

370 total trials

Why NCT01850589 stopped before completion

NCT01850589 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Aggressive Therapy is the first listed.

NCT01850589 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01850589 about?

NCT01850589 is a clinical study titled "Comparison of Conservative and Aggressive Smoking Cessation Treatment Strategies in a Vascular Surgery Office Practice". The aim of this study is to prove that the use of Bupropion with counseling works better than counseling alone for patients to quit smoking. The belief is that overall, there is a small percentage of patients who quit smoking all together.

What is the current status of trial NCT01850589?

This trial is currently terminated. It is a NA study. The enrollment target is 44 participants. The study started on 2011-03. Estimated completion is 2013-01.

What interventions are being tested in trial NCT01850589?

The interventions under investigation include: Aggressive Therapy (OTHER).

Who is sponsoring clinical trial NCT01850589?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01850589's enrollment target sits among peer trials

44 1423rd of 2000 higher than 566 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323945 · 44 participants · NA

    Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury

  • NCT03093909 · 44 participants · Phase 1

    Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

  • NCT03104491 · 44 participants · Phase 1

    Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • NCT03781765 · 44 participants · Phase 4

    Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01850589, the US trial registry maintained by the National Library of Medicine. NCT01850589 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.